HERZUMA is a prescription medicine used in adults for the treatment of early-stage breast cancer that is H uman E pidermal growth factor R eceptor 2 -positive (HER2+) and has spread into …

Jan 7, 2025 · Herzemab is a recombinant humanized IgG1 monoclonal antibody against the HER-2 receptor, a member of the epidermal growth factor receptors which is a photo-oncogene. …

Mar 26, 2025 · Herzuma is used to treat certain types of breast cancer or stomach cancer, sometimes in combination with other cancer medicines. Herzuma is sometimes used when the …

HERZUMA (trastuzumab-pkrb) is biosimilar* to HERCEPTIN (trastuzumab). Cardiomyopathy: Trastuzumab products can result in subclinical and clinical cardiac failure manifesting as CHF, …

HERZUMA is indicated in adults, in combination with cisplatin and capecitabine or 5-fluorouracil, for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal …

On December 14, 2018, the Food and Drug Administration approved Herzuma (trastuzumab-pkrb, Celltrion Inc.) as a biosimilar to Herceptin (trastuzumab, Genentech Inc.) for patients with...

HERZEMAB bisa dikombinasikan dengan kemoterapi taxane (paclitaxel atau docetaxel), capecitabine atau 5-FU dan platinum, vinorelbine. Hingga berapa lama HERZEMAB …

Jul 1, 2019 · Interrupt HERZUMA infusion for dyspnea or clinically significant hypotension. Monitor patients until symptoms completely resolve. Discontinue HERZUMA for anaphylaxis, …

Herzuma in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of adult patients with HER2 positive metastatic adenocarcinoma of the stomach or …

Jan 12, 2021 · Herzemab adalah obat antikanker untuk mengobati kanker payudara stadium dini dan metastatik (penyebaran sel kanker), serta kanker gaster stadium lanjut. Herzemab adalah …